Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) Other Non Operating Income (2020 - 2025)

Quantum Biopharma's Other Non Operating Income history spans 6 years, with the latest figure at -$11.8 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 12003.53% to -$11.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.4 million, a 6389.89% decrease, with the full-year FY2025 number at -$11.9 million, down 11498.54% from a year prior.
  • Other Non Operating Income hit -$11.8 million in Q4 2025 for Quantum Biopharma, down from $1.3 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for QNTM hit a ceiling of $3.1 million in Q1 2025 and a floor of -$11.8 million in Q4 2025.
  • Historically, Other Non Operating Income has averaged -$520179.1 across 5 years, with a median of $104797.0 in 2024.
  • The widest YoY moves for Other Non Operating Income: up 1690813.51% in 2025, down 12003.53% in 2025.
  • Tracing QNTM's Other Non Operating Income over 5 years: stood at -$294947.0 in 2021, then plummeted by 415.64% to -$1.5 million in 2022, then skyrocketed by 113.96% to $212256.0 in 2023, then plummeted by 53.2% to $99327.0 in 2024, then plummeted by 12003.53% to -$11.8 million in 2025.
  • Business Quant data shows Other Non Operating Income for QNTM at -$11.8 million in Q4 2025, $1.3 million in Q3 2025, and $110267.0 in Q2 2025.